Literature DB >> 2840866

Practical usefulness of lymphatic and connective tissue clearance for the carcinoma of the pancreas head.

O Ishikawa1, H Ohhigashi, Y Sasaki, T Kabuto, I Fukuda, H Furukawa, S Imaoka, T Iwanaga.   

Abstract

We performed a retrospective review of 59 pancreatic resections for ductal carcinoma of the pancreas head performed between 1971 and 1983. In addition to pancreaticoduodenectomy, 37 consecutive patients (from 1971 to 1981) received lymphatic dissection adjacent to the pancreatic head (Group R1), whereas another 22 patients (from 1981 to 1983) received a wider range of lymphatic and soft tissue dissection, including the para-aortic region (Group R2). These groups did not differ with regard to operative mortality rate or background factors in the patients who tolerated operation. The 3-year cumulative survival rate was 13% in the R1 group vs. 38% in the R2 group (p less than 0.05). Almost all of the deaths from cancer recurrence occurred within 3 years after operation; the cumulative rate of death from local recurrence decreased from 67 to 16% (p less than 0.05) at 3 years. Among the patients with nodal involvement, there was no 3-year survivor in the R1 group, but four (27%) in the R2 group (p less than 0.05) survived. Among the patients whose tumor size exceeded 4 cm with retroperitoneal invasion, there was no 3-year survivor in either group and most patients died of distant metastasis. Extended clearance of regional lymph nodes and soft tissue appears to benefit patients with ductal carcinoma of the pancreatic head whose tumor size is less than 4 cm without severe invasion to the retroperitoneal space.

Entities:  

Mesh:

Year:  1988        PMID: 2840866      PMCID: PMC1493620          DOI: 10.1097/00000658-198808000-00014

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  13 in total

1.  RADICAL PANCREATODUODENECTOMY: A 22-YEAR EXPERIENCE WITH THE COMPLICATIONS, MORTALITY RATE, AND SURVIVAL RATE.

Authors:  J J MONGE; E S JUDD; R P GAGE
Journal:  Ann Surg       Date:  1964-10       Impact factor: 12.969

2.  Results of radical resection for periampullary cancer.

Authors:  K W Warren; D S Choe; J Plaza; M Relihan
Journal:  Ann Surg       Date:  1975-05       Impact factor: 12.969

3.  Attempted curative resection of ductal carcinoma of the pancreas: review of Mayo Clinic experience, 1951-1975.

Authors:  A J Edis; P D Kiernan; W F Taylor
Journal:  Mayo Clin Proc       Date:  1980-09       Impact factor: 7.616

4.  Lymph node involvement in carcinoma of the head of the pancreas area.

Authors:  A L Cubilla; J Fortner; P J Fitzgerald
Journal:  Cancer       Date:  1978-03       Impact factor: 6.860

5.  Histopathology in the evaluation of total pancreatectomy for ductal carcinoma.

Authors:  A F Tryka; J R Brooks
Journal:  Ann Surg       Date:  1979-09       Impact factor: 12.969

6.  Carcinoma of the pancreas: review of MGH experience from 1963 to 1973. Analysis of surgical failure and implications for radiation therapy.

Authors:  J Tepper; G Nardi; H Sutt
Journal:  Cancer       Date:  1976-03       Impact factor: 6.860

7.  Regional pancreatectomy for cancer of the pancreas, ampulla, and other related sites. Tumor staging and results.

Authors:  J G Fortner
Journal:  Ann Surg       Date:  1984-04       Impact factor: 12.969

8.  Total pancreatectomy for cancer. An appraisal of 65 cases.

Authors:  I Ihse; P Lilja; B Arnesjö; S Bengmark
Journal:  Ann Surg       Date:  1977-12       Impact factor: 12.969

9.  Pancreaticoduodenectomy. A 40-year experience.

Authors:  J R Cohen; N Kuchta; N Geller; G T Shires; P Dineen
Journal:  Ann Surg       Date:  1982-05       Impact factor: 12.969

10.  Surgical experience with pancreatic and periampullary cancer.

Authors:  F P Herter; A M Cooperman; T N Ahlborn; C Antinori
Journal:  Ann Surg       Date:  1982-03       Impact factor: 12.969

View more
  75 in total

Review 1.  Adjuvant therapy in pancreatic cancer.

Authors:  P Ghaneh; J Slavin; R Sutton; M Hartley; J P Neoptolemos
Journal:  World J Gastroenterol       Date:  2001-08       Impact factor: 5.742

Review 2.  Neoadjuvant, adjuvant, and palliative treatment of pancreatic cancer.

Authors:  D Birk; H G Beger
Journal:  Curr Gastroenterol Rep       Date:  2001-04

3.  Pathomorphological and histological prognostic factors in curatively resected ductal adenocarcinoma of the pancreas.

Authors:  W Meyer; C Jurowich; M Reichel; B Steinhäuser; P H Wünsch; C Gebhardt
Journal:  Surg Today       Date:  2000       Impact factor: 2.549

4.  Evaluation of surgical risk in palliation and resection of pancreatic cancer. Perspective study and tables to calculate the risk.

Authors:  S Pedrazzoli; B Bonadimani; C Sperti; C Pasquali; F Cappellazzo; S Catalini; A Piccoli; C Militello
Journal:  Int J Pancreatol       Date:  1992-12

5.  Staging of cancer of the pancreas.

Authors:  J E Trapnell
Journal:  Int J Pancreatol       Date:  1990 Aug-Nov

6.  Analysis of 5-year survivors after a macroscopic curative pancreatectomy for invasive ductal adenocarcinoma.

Authors:  Kazuaki Shimada; Yoshihiro Sakamoto; Satoshi Nara; Minoru Esaki; Tomoo Kosuge; Nobuyoshi Hiraoka
Journal:  World J Surg       Date:  2010-08       Impact factor: 3.352

Review 7.  Pylorus-preserving pancreatoduodenectomy--technical aspects.

Authors:  J W Braasch; M Gagner
Journal:  Langenbecks Arch Chir       Date:  1991

8.  Pancreatic adenocarcinoma.

Authors:  Margaret A Tempero; J Pablo Arnoletti; Stephen Behrman; Edgar Ben-Josef; Al B Benson; Jordan D Berlin; John L Cameron; Ephraim S Casper; Steven J Cohen; Michelle Duff; Joshua D I Ellenhorn; William G Hawkins; John P Hoffman; Boris W Kuvshinoff; Mokenge P Malafa; Peter Muscarella; Eric K Nakakura; Aaron R Sasson; Sarah P Thayer; Douglas S Tyler; Robert S Warren; Samuel Whiting; Christopher Willett; Robert A Wolff
Journal:  J Natl Compr Canc Netw       Date:  2010-09       Impact factor: 11.908

Review 9.  Survival after surgical management of pancreatic adenocarcinoma: does curative and radical surgery truly exist?

Authors:  H G Smeenk; T C K Tran; J Erdmann; C H J van Eijck; J Jeekel
Journal:  Langenbecks Arch Surg       Date:  2004-05-14       Impact factor: 3.445

10.  Staging of carcinoma of the pancreas and ampulla of Vater. Tumor (T), lymph node (N), and distant metastasis (M) as prognostic factors.

Authors:  K E Bakkevold; B Kambestad
Journal:  Int J Pancreatol       Date:  1995-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.